Our findings suggested that reducing TGM2 expression increased ESCC cell radiosensitivity and inhibited proliferation after RT by suppressing HR repair, indicating that it may represent a promising target for sensitization in the clinical management of ESCC. This evidence concerns the gene TGM2 and esophageal squamous cell carcinoma.